Prognostic Factors in Human Colorectal Cancer

Al-Sheneber I.F. , Shibata H.R. , Sampalis J. , Jothy S. : Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer, 71: 1954–1959, 1993.

Bosari S. , Lee A.K.C. , Wiley B.D. , Heatley G.J. , Silverman M.L. : Flow cytometric and image analyses of colorectal adenocarcinomas. Am. J. Clin. Pathol., 99: 187–194, 1993.

Bosari S. , Viale G. , Bossi P. , Maggioni M. , Coggi G. , Murray J.J. , Lee A.K.C. : Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J. Natl. Cancer Inst., 86: 681–687, 1994.

Bossi P. , Viale G. , Lee A.K.C. , Alfano R.M. , Coggi G. , Bosari S. : Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathologic correlations. Cancer Res., 55: 5049–5053, 1995.

Chapman M.A.S. , Hardcaste J.D. , Armitage N.C.M. : Five-year prospective study of DNA tumor ploidy and colorectal cancer survival. Cancer, 76: 383–387, 1995.

Clark J.I. , Berger S.L. , Mittelman A. : Thymidylate synthase gene amplification in a colon tumor resistant to fluoropyrimidine chemotherapy. Cancer Treat. Rep., 71: 261–265, 1987.

Cohen A.M. , Tremiterra S. , Candela F. , Thaler H.T. , Sigurdson E.R. : Prognosis of node-positive colon cancer. Cancer, 67: 1859–1861, 1991.

Eisenberg B. , Decosse J.J. , Harford F. , Michaelek J. : Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients. Cancer, 49: 1131–1134, 1982.

Fearon E.R. , Vogelstein B. : A genetic model for colorectal tumorigenesis. Cell, 61: 759–767, 1990.

Flamini G. , Curigliano G. , Ratto C. , Astone A. , Ferretti G. , Nucera P. , Sofo L. , Sgambato A. , Boninsegna A. , Crucitti F. , Cittadini A. : Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis. Eur. J. Cancer, 32: 802–806, 1996.

Folkman J. : Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757–1763, 1995.

Freedman L.S. , Macaskill P. , Smith A.N. : Multivariate analysis of prognostic factors for operable rectal cancer. Lancet, ii: 733–736, 1984.

Gasparini G. , Harris A.L. : Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J. Clin. Oncol., 13: 765–782, 1995.

Hagmuller E. , Lorenz D. , Sturm J. , Richter A. , Trede M. : Long-term survival after resection of locally advanced colorectal carcinoma. Zentralblatt fur Chirurgie, 120: 815–820, 1995.

Hamelin R. , Puig P.L. , Olschwang S. , Jego N. , Asselain B. , Remvikos Y. , Girodet J. , Salmon R.J. , Thomas G. : Association of p53 mutations with short survival in colorectal cancer. Gastroenterology, 106: 42–48, 1994.

Harlow S.P. , Eriksen B.L. , Poggensee L. , Chmiel J.S. , Scarpelli D.G. , Murad T. , Bauer K.D. : Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas. Cancer Res., 51: 2403–2409, 1991.

Jonhston P.J. , Drake J.C. , Trepel J. : Immunological quantitation of thymidylate synthase using monoclonal antibody Ts 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res., 52: 4306–4312, 1992.

Jonhston P.G. , Fisher E.R. , Rockette H.E. , Fisher B. , Wolmark N. , Drake J.C. , Chabner B.A. , Allegra C.J. : The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J. Clin. Oncol., 12: 2640–2647, 1994.

Jonhston P.J. , Lenz H.J. , Leichman C.G. , Danenberg K.D. , Allegra C.J. , Danenberg P.V. , Leichman L. : Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res., 55: 1407–1412, 1995.

Kotanagi H. , Fukukoa T. , Shibata Y. , Yoshioka T. , Aizawa O. , Saito Y. , Koyama K. : Blood vessel invasion in metastatic nodes for development of liver metastases in colorectal cancer. Hepato-Gastroenterology, 42: 771–774, 1995.

Lenz H.J. , Danenberg K.D. , Jonhston P.J. , Florentine B. , Leichman C.G. , Hayashi K. , Metzger R. , Leichman L. : p53 status and thymidylate synthase expression are associated and predict for recurrence in patients with stage II colon cancer. Proc. Am. Soc. Clin. Oncol., 15: 215, 1996.

Lenz H.J. , Danenberg K.D. , Leichman C.G. , Hayashi K. , Metzger R. , Salinga D. , Kortes V. , Banerjee D. , Bertino J.R. , Groshen S. , Leichman L. , Danenberg P.V. : p53 status and thymidylate synthase levels are predictors of chemotherapy efficacy in patients with advanced colorectal cancer. Proc. Am. Soc. Clin. Oncol., 15: 216, 1996.

Mayer A. , Takimoto M. , Fritz E. , Schellander G. , Kofler K. , Ludwig H. : The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer, 71: 2454–2460, 1993.

Michelassi F. , Vannucci L. , Ayala J.J. : Local recurrence after curative resection of colorectal adenocarcinoma. Surgery, 108: 787–793, 1990.

Minsky B.D. , Mies C. , Recht A. , Rich T.A. , Chaffey J.T. : Resectable adenocarcinoma of the rectosigmoid and rectum. Cancer, 61: 1408–1416, 1988.

Mulder J-W.R. , Baas I.O. , Polak M.M. , Goodman S.N. , Offerhaus G.J.A. : Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br. J. Cancer, 71: 1257–1262, 1995.

Newland R.C. , Chapius P.H. , Smyth E.J. : The prognostic value of substaging colorectal cancer carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer, 60: 852–857, 1987.

Newland R.C. , Dent O.F. , Lyttle M.N.B. , Chapius P.H. , Bokey E.L. : Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. Cancer, 73: 2076–2082, 1994.

Peters G.J. , van der Wilt C.L. , van Triest B. , Codacci-Pisanelli G. , Jonhston P.G. , van Groeningen C.J. , Pinedo H.M. : Thymidylate synthase and drug resistance. Eur. J. Cancer, 31: 1299–1305, 1995.

Pietra N. , Sarli L. , Sansebastiano G. , Saccani Jotti G. , Peracchia A. : Prognostic value of ploidy, cell proliferation kinetics, and conventional clinicopathologic criteria in patients with colorectal carcinoma: a prospective study. Dis. Colon Rectum, 39: 494–503, 1996.

Shibata D. , Reale M.A. , Lavin P. , Silverman M. , Fearon E.R. , Steele G. , Jessup J.M. , Loda M. , Summerhayes I.C. : The DCC protein and prognosis in colorectal cancer. N. Engl. J. Med., 335: 1727–1732, 1996.

Silvestrini R. , D'Agnano I. , Faranda A. , Costa A. , Zupi G. , Cosimelli M. , Quagliuolo V. , Giannarelli D. , Gennari L. , Cavaliere R. : Flow cytometric analysis of ploidy in colorectal cancer: a multicenter experience. Br. J. Cancer, 67: 1042–146, 1993.

Takebayashi Y. , Akiyama S. , Akiba S. , Yamada K. , Miyadera K. , Sumizawa T. , Yamada Y. , Murata F. , Aikou T. : Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J. Natl. Cancer Inst., 88: 1110–1117, 1996.

Tang R. , Ho Y-S. , You Y.T. , Hsu K.C. , Chen J.S. , Changchien C.R. , Wang J.Y. : Prognostic evaluation of DNA flow cytometric and histopathologic parameters of colorectal cancer. Cancer, 76: 1724–1730, 1995.

Tang R. , Wang Y.J. , Chen J.S. , Chang-Chien C.R. , Tang S. , Lin S.E. , You Y.T. , Hsu K.C. , Ho Y.S. , Fan H.A. : Survival impact of lymph node metastasis in TNM stage II carcinoma of the colon and rectum. J. Am. Coll. Surg., 180: 705–712, 1995.

Van Langenberg A.V. , Ong B.B. : Carcinoma of the large bowel in the young. Br. Med. J., 3: 374–376, 1972.

van Triest B. , Pinedo H.M. , van Groeningen C.J. , Veenhof C.H.N. , Kuiper C.M. , Tellman F. , Peters G.J. : Expression and regulation of thymidylate synthase, p53 and bcl-2 in colon carcinoma. Proc. Am. Soc. Clin. Oncol., 15: 231, 1996.

Zeng Z-S. , Sarkis A.S. , Zhang Z-F. , Klimstra D.S. , Charytonowicz E. , Guillem J.G. , Cordon-Cardo C. , Cohen A.M. : p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J. Clin. Oncol., 12: 2043–2050, 1994.